These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1190237)

  • 1. Etiological factors of the Stevens-Johnson syndrome.
    Vanderveen TW; Robinson LA; Ray MD
    Am J Hosp Pharm; 1975 Nov; 32(11):1149-53. PubMed ID: 1190237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stevens-Johnson syndrome associated with Mycoplasma pneumoniae infections.
    Sontheimer RD; Garibaldi RA; Krueger GG
    Arch Dermatol; 1978 Feb; 114(2):241-4. PubMed ID: 629550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson syndrome from ophthalmic sulfonamide.
    Gottschalk HR; Stone OJ
    Arch Dermatol; 1976 Apr; 112(4):513-4. PubMed ID: 1267457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome following sulfadiazine, Tri-sulfose and sulfatriad therapy.
    Sharma R; Mathur MN
    J Assoc Physicians India; 1965 Sep; 13(9):727-30. PubMed ID: 5840521
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis.
    Patterson R; Miller M; Kaplan M; Doan T; Brown J; Detjen P; Grammer LC; Greenberger PA; Hogan MB; Latall J
    Ann Allergy; 1994 Jul; 73(1):27-34. PubMed ID: 8030799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-induced Stevens-Johnson syndrome in a patient with AIDS].
    Schlienger RG; Haefeli WE; Bircher A; Leib SL; Lüscher TF
    Schweiz Rundsch Med Prax; 1993 Aug; 82(33):888-92. PubMed ID: 8372290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of the Stevens-Johnson syndrome (erythema exudativum multiforme) and severe skin reactions with relation to sulfonamide therapy. Reply to questions sent to a Norwegian hospital].
    Tidsskr Nor Laegeforen; 1966 Sep; 86(17):1207-9. PubMed ID: 4224656
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
    Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
    J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of Lyell's and Stevens-Johnson syndromes: etiological role of drugs].
    Monnat A
    Schweiz Med Wochenschr; 1972 Dec; 102(52):1906-11. PubMed ID: 4660388
    [No Abstract]   [Full Text] [Related]  

  • 13. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures.
    Strom BL; Carson JL; Halpern AC; Schinnar R; Snyder ES; Shaw M; Tilson HH; Joseph M; Dai WS; Chen D
    Arch Dermatol; 1991 Jun; 127(6):831-8. PubMed ID: 2036028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Stevens-Johnson syndrome.
    Crosby SS; Murray KM; Marvin JA; Heimbach DM; Tartaglione TA
    Clin Pharm; 1986 Aug; 5(8):682-9. PubMed ID: 3742953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic complications and management of Stevens-Johnson syndrome at a tertiary eye care centre in south India.
    Kompella VB; Sangwan VS; Bansal AK; Garg P; Aasuri MK; Rao GN
    Indian J Ophthalmol; 2002 Dec; 50(4):283-6. PubMed ID: 12532492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection.
    Porteous DM; Berger TG
    Arch Dermatol; 1991 May; 127(5):740-1. PubMed ID: 1827245
    [No Abstract]   [Full Text] [Related]  

  • 17. Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome.
    Shilad A; Predanic M; Perni SC; Houlihan C; Principe D
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1254-6. PubMed ID: 15863600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
    Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC
    Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drugs as an etiological factor in the Stevens-Johnson's syndrome].
    Rev Clin Esp; 1969 Jan; 112(1):99-100. PubMed ID: 5766961
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpes simplex virus associated with recurrent Stevens-Johnson syndrome. A management strategy.
    Detjen PF; Patterson R; Noskin GA; Phair JP; Loyd SO
    Arch Intern Med; 1992 Jul; 152(7):1513-6. PubMed ID: 1627031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.